7 news items
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
GRTS
29 Apr 24
. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
GRTS
8 Apr 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
GRTS
1 Apr 24
innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we
Gritstone bio Announces Proposed Public Offering
GRTS
1 Apr 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
8pold47one1np576fhaombip3crfwxki7890hskxx hjshgmdsvcs
GRTS
1 Apr 24
critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat and prevent viral
tm5qxxl2dl0u kdftfbreh1ayrlmw
GRTS
5 Mar 24
system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat
- Prev
- 1
- Next